takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Stephen W. Kaldor Ph.D.
|Age||Total Calculated Compensation||This person is connected to 18 board members in 3 different organizations across 10 different industries.|
See Board Relationships
Mr. Stephen W. Kaldor, also known as Steve, PhD, serves as Acting Chief Executive Officer Quanticel Pharmaceuticals, Inc. Mr. Kaldor serves as an Advisor at Thomas, McNerney & Partners and advises on drug discovery. He served as an Advisor of Achaogen, Inc. He is a Venture Partner at Versant Ventures Inc. He is an Associate Editor of the Journal of Combinatorial Chemistry (ACS). He gained over 12 years of research and development, drug discovery and development experience ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Director, Member of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|